Short description
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.
Description
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.The Dynacure team leverages its proven track record in rare disease drug development to build a pipeline of novel drugs. Dynacure is developing DYN101, an investigational antisense medicine designed to modulate the expression of dynamin 2 for the treatment of Centronuclear Myopathies, with Ionis Pharmaceuticals. Dynacure is also building a complementary research portfolio targeting other orphan disorders.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Illkirch, Alsace, France, Europe
Founded on
January 1, 2016
Exited on
March 2, 2023
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access
Investors
No Way, Uh Ohhhh, Blurry Noaccess, No Way, Noaccess, Absolutely Noaccess, Cannot Access
Sign in for full access